Friday, 29 March 2024

Announcement

RELINT: RYM: Disclosure of Directors and Officers Relevant Interests

18 Aug 2011 16:16NZX
Ongoing Disclosure Notice
Disclosure of Directors and Officers Relevant Interests

Section 19T(2), Securities Markets Act 1988

A Details of director or officer
Name of director or officer of public issuer:  David William Kerr

Name of public issuer:  Ryman Healthcare Ltd
Name of related body corporate (if applicable):
Position held in public issuer:  Director

B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: 1 ) 903,352 Ordinary
shares

C Nature of relevant interest and name of registered holder

Nature of relevant interest in those securities: 2)  Registered
Holder, as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme

Name of registered holder of those securities 3)  David William
Kerr and Andrew John Clements

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 4)  N/a
Consideration paid for acquisition: 5)  N/a

If the relevant interest was disposed of--
Date of disposal: 6)  11 August 2011
Consideration received for disposal: 7 ) Transfer of 903,352 shares to
Ryman Employees in accordance with three year vesting terms of the Ryman
Healthcare Limited Employee Share Purchase Scheme.

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place: 8)      Transfer of shares to
Ryman Employees in accordance with three year vesting terms of the Ryman
Healthcare Limited Employee Share Purchase Scheme.

E Total number of transactions this notice relates to: 9)  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 10   )   20 August 2010

G Signature
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Gordon MacLeod
Date of signature:  18 August 2011
Name and title of authorised person:  Gordon MacLeod, CFO & Company
Secretary

Ongoing Disclosure Notice
Disclosure of Directors and Officers Relevant Interests

Section 19T(2), Securities Markets Act 1988

A Details of director or officer
Name of director or officer of public issuer:  David William Kerr

Name of public issuer:  Ryman Healthcare Ltd
Name of related body corporate (if applicable):
Position held in public issuer:  Director

B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: 1)  836,628 Ordinary
shares

C Nature of relevant interest and name of registered holder

Nature of relevant interest in those securities: 2)  Registered
Holder, as Custodian for Ryman Healthcare Ltd Employee Share Purchase Scheme

Name of registered holder of those securities 3)  David William
Kerr and Andrew John Clements

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 4)  11 August 2011
Consideration paid for acquisition: 5)  $2,125,000 (or $2.53 per
share)

If the relevant interest was disposed of--
Date of disposal: 6)  N/a
Consideration received for disposal: 7)  N/a

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place: 8)      On market purchase

E Total number of transactions this notice relates to: 9)  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 10)   20 August 2010

G Signature
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Gordon MacLeod
Date of signature:  18 August 2011
Name and title of authorised person:  Gordon MacLeod, CFO & Company
Secretary

Notes:
Use this form to disclose all the acquisitions and disposals by a director or
officer of a public issuer of relevant interests in securities of the public
issuer or of a related body corporate. The disclosure must normally be made
within 5 trading days of the first acquisition or disposal disclosed in this
notice
"Provide the information required under headings C and D for each type of
security identified under heading B.
"
"This notice must be signed either by the director or officer making the
disclosure, or by a person authorised by the director or officer to sign on
his or her behalf.11
"

References
1.  Regulation 8.
2.  Regulation 7.
3.  Regulation 7.
4.  Regulation 9.
5.  Regulation 10.
6.  Regulation 9.
7.  Regulation 10.
8.  Regulation 11.
9.  Regulation 12 (2)
10.  Regulation 13.
11. Regulation 14.
End CA:00212568 For:RYM    Type:RELINT     Time:2011-08-18 16:16:09
Views: 456
Ryman Healthcare Ordinary Shares
 10.72 Change:
0.02
0.19%
 
Open:10.74 
High:10.74 
Low:10.74 
Volume:6,079 
Last Traded:07/02/18 09:14:52 
Bid:10.73 
Ask:10.68 
52-Wk High:11.30 
52-Wk Low:8.12